MedTrace Logo

The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy

NCT01306760 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-09-08

No results posted yet for this study

Summary

The main aim of this research is to ascertain whether Ketamine would be a more effective anaesthetic for Electroconvulsive Therapy (ECT) than the standard anaesthetic. In doing so the investigators aim to examine the effect of ketamine on ratings of depressive symptoms, the number of required ECT treatments, and the effect of this anaesthetic on memory.

Conditions

Interventions

DRUG

Ketamine

Ketamine used as the anaesthetic during ECT.

DRUG

Propofol

The standard anaesthetic used for ECT.

Sponsors & Collaborators

  • NHS Grampian

    collaborator OTHER_GOV

  • Chief Scientist Office of the Scottish Government

    collaborator OTHER_GOV

  • University of Aberdeen

    lead OTHER

Principal Investigators

  • Ian C Reid, PhD · University of Aberdeen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01306760 on ClinicalTrials.gov